Keyword: 340B Health

Cuts to the reimbursement rate under the 340B drug program by HHS were unlawful, a U.S. district judge for the District Court of D.C. has ruled.

The 340B drug discount program may actually hurt patient access to costly drugs as hospitals take advantage of the program, according to a new report.

The Health Resources & Services Administration (HRSA) launched an online tool that 340B hospitals can use to see what companies can charge for drugs.

CVS Caremark has put the brakes on a plan to cut payments to 340B providers—much to the joy of those hospitals.

Healthcare PE firm WindRose took in $705 million in its fifth fund, plus more healthcare headlines.

Humana members who use the insurer's virtual wellness and rewards program have new offerings, plus more payer headlines.

HHS has finalized plans to roll out the final rule for the 340B drug discount program, which would set price ceilings and monetary penalties.

The administration has overstepped its boundaries, and patients will suffer under the rule, said AHA's president. Physician organizations disagree.

HHS is planning an about-face on the long-delayed rule that would set price ceilings and monetary penalties in the 340B program.

CEOs from more than 700 hospitals sent a letter to congressional leaders, calling on them to protect the 340B drug discount program.